OnCo
Start hereTagsprevention

prevention

All tags →

No description yet: the sentence for this tag has not been written. 13 records carry it: 5 drugs, 4 people, 2 terms, 1 front, 1 company.

13 records
Aminolevulinic acid (topical, for photodynamic therapy)
Levulan Kerastick / Ameluz
Aminolevulinic acid is painted on sun-damaged skin and then activated with a lamp, destroying actinic keratoses before they can become skin cancer; in Europe the gel is also approved for superficial basal cell carcinoma.
Approved
Andrea DeCensi
Medical oncologist, E.O. Ospedali Galliera, Genoa · E.O. Ospedali Galliera
Italian oncologist who led TAM-01, the trial that showed a low dose of tamoxifen halves recurrence after non-invasive breast cancer with fewer side effects than the standard dose.
Aspirin
Aspirin is not a cancer drug but sits in cancer care in two places: low doses prevent clots in polycythaemia vera and essential thrombocythaemia, and long-term use lowers colorectal cancer in people with Lynch syndrome, while a trial in the healthy elderly found no benefit and possible harm.
Established
Diet, Exercise & Lifestyle
What people eat, drink, weigh and do affects who gets cancer, how treatment goes, and who relapses. This front studies that with the rigour of a drug trial.
Family Smoking Prevention and Tobacco Control Act 2009
The 2009 US law that finally gave the FDA power over tobacco products, the cause of roughly a third of cancer deaths, including authority to ban flavours, restrict marketing and set nicotine levels, though it may not ban cigarettes or nicotine outright.
HPV bivalent vaccine (types 16 and 18)
Cervarix
Cervarix is a vaccine against HPV types 16 and 18, the two types that cause most cervical cancers, authorised in the EU in 2007 and the US in 2009 after the 18,000-woman PATRICIA trial showed near-complete protection against type-specific precancer. GSK withdrew it from the US in 2016, but it remains WHO-prequalified and used in national programmes, including single-dose schedules.
Approved2007🇪🇺
HPV quadrivalent vaccine (types 6, 11, 16 and 18)
Gardasil
Gardasil was the first HPV vaccine, licensed in 2006 to prevent cervical and other genital cancers and genital warts. It has been replaced in most countries by the nine-type version, Gardasil 9.
Approved2006🇪🇺
Jack Cuzick
Professor of Epidemiology, Wolfson Institute of Population Health, Queen Mary University of London · Barts Cancer Institute / Barts Health NHS Trust
Epidemiologist who led IBIS-I and IBIS-II, proving tamoxifen and anastrozole prevent breast cancer in high-risk women.
Nubia Muñoz
Emeritus Professor, National Cancer Institute of Colombia; former Chief of Field and Intervention Studies, IARC · Instituto Nacional de Cancerología (Colombia)
Colombian epidemiologist whose IARC studies proved HPV causes cervical cancer and identified the types the vaccines target.
Peter Sasieni
Professor of Cancer Epidemiology, Queen Mary University of London; Director, Cancer Prevention Trials Unit · Barts Cancer Institute / Barts Health NHS Trust
Epidemiologist who showed HPV vaccination has nearly eliminated cervical cancer in vaccinated English women and leads NHS-Galleri.
Raloxifene
Evista
Raloxifene (Evista) is an osteoporosis tablet that also lowers the chance of developing invasive breast cancer in postmenopausal women at higher risk, with fewer womb-cancer problems than tamoxifen.
Approved
SciRouter
United States (head office not published), US
SciRouter is a prevention-first longevity start-up founded by Ryan Bethencourt that sells plant-based daily supplements for people, dogs and cats, and frames cancer and age-related decline as engineering problems to be prevented rather than treated.
Tobacco 21
Since December 2019 it has been illegal across the United States to sell tobacco or vaping products to anyone under 21, a rule that started in one Massachusetts town and spread state by state, aimed at the years when most smokers start.

This tag as JSON · API